相关实验视频
Updated: Jan 16, 2026

10:40
Author Spotlight: Insight Into Advances in Prion Diseases Research
Published on: August 11, 2023
813
抑制CK2抑制了大脑中的质炎症
bioRxiv : the preprint server for biology
|October 1, 2025
概括
蛋白激酶CK2 (CK2) 通过激活质细胞,驱动阿尔茨海默病 (AD) 中的神经炎症. 抑制CK2可以减少炎症,并显示AD和相关的神经退行性疾病的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 由激活的星球细胞和微质细胞驱动的神经炎症,在阿尔茨海默氏症 (AD) 中显著导致神经元损伤.
- 在神经退行性疾病中调节质炎症反应的精确机制尚未完全理解.
- 慢性质细胞激活释放炎症媒介,加剧氧化应激,促进蛋白质分解,导致神经元功能障碍.
研究的目的:
- 在神经退行性疾病的背景下,识别神经细胞炎症的关键分子调节剂.
- 研究蛋白质激酶CK2 (CK2) 在中介神经炎症中的作用.
- 评估CK2抑制作为阿尔茨海默病的潜在治疗策略.
主要方法:
- 化学蛋白质查以确定CK2作为星球细胞炎症的关键调节剂.
- 生物化学试验以确定CK2的作用机制,包括NF-κB通路的酸化.
- 在体外研究中使用患者衍生的星球细胞和皮质器官.
- 使用急性神经炎症小鼠模型和用CK2抑制剂 (TAL606) 治疗的转基因AD小鼠进行体内研究.
主要成果:
- 化学蛋白质组学确定了CK2,特别是CK2α2亚单元,是天体细胞炎症的关键驱动因素.
- CK2通过化关键成分 (NF-κB S529,IκBα S32) 来增强NF-κB信号传递,从而增加了促炎性基因表达 (IL-6,IL-8).
- 在小鼠模型和患者衍生的星形细胞中,CK2抑制有效地抑制了神经炎症;CK2α2在AD组织和星形细胞中被上调,其过度表达模仿了有机体中的AD病理.
结论:
- CK2是神经炎症的中央调节者,特别是在星球细胞中.
- 准CK2,特别是CK2α2亚单元,为阿尔茨海默病提供了一个有前途的治疗途径.
- 通过TAL606证明的选择性CK2抑制可以减轻炎症标志物,并有可能治疗神经退行性疾病.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.8K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Glial Cells
93.2K
Overview
93.2K
Nervous Tissue: Glial Cells
6.5K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
6.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
827
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
827

